Related Experiment Video

Updated: Jul 13, 2026

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis
10:23

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis

Published on: April 17, 2017

Lipid metabolism in children with chronic hepatitis C, A preliminary report

Malgorzata Wisniewska-Ligier1, Teresa Wozniakowska-Gesicka, Joanna Kups

  • 1III Department of Pediatrics, Polish Mother's Hospital, Research Institute, Lodz, Poland.

Hepato-Gastroenterology
|December 13, 2006
PubMed

Insights

Children with chronic hepatitis C show lower cholesterol levels and minimal steatosis, suggesting a potential risk for future fatty liver disease and its complications.

Area of Science:

  • Hepatology
  • Pediatric Gastroenterology
  • Lipid Metabolism

Background:

  • Lipid metabolism plays a role in chronic hepatitis C pathogenesis.
  • Understanding risk factors for cirrhosis and cancer in children with hepatitis C is crucial.
  • Assessing lipid profiles in pediatric HCV infection is important for long-term outcomes.

Purpose of the Study:

  • To evaluate lipid metabolism in children diagnosed with chronic hepatitis C.
  • To identify potential risk factors for advanced liver disease in pediatric HCV patients.

Main Methods:

  • A comparative study involving 16 children with chronic hepatitis C and 16 healthy controls.
  • Anthropometric measurements and serum levels of bilirubin, liver enzymes, total cholesterol, LDL-C, HDL-C, and triglycerides were analyzed.
  • Liver biopsy specimens were assessed in the study group.

Main Results:

  • Three children exhibited macrovesicular steatosis.
  • Significantly lower total cholesterol levels were observed in children with chronic hepatitis C compared to controls (p < 0.05).
  • No significant differences were found in BMI, bilirubin, HDL-C, LDL-C, triglycerides, or HDL/C index; no correlations were found between lipid parameters and histological/clinical factors.

Conclusions:

  • Obesity and hyperlipidemia were not prevalent risk factors for steatosis in pediatric HCV patients.
  • Lower cholesterol levels and scarce steatosis in children with HCV may indicate an early risk for fatty liver disease progression, including cirrhosis and cancer.
Abstract

More Related Videos

Inducing and Characterizing Vesicular Steatosis in Differentiated HepaRG Cells09:15

Inducing and Characterizing Vesicular Steatosis in Differentiated HepaRG Cells

Published on: July 18, 2019

Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish09:27

Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish

Published on: April 1, 2021

Related Concept Videos

Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Lipid Catabolism01:25

Lipid Catabolism

Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...